# NYSTATIN AND TRIAMCINOLONE ACETONIDE
> **ANDA208479** · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2017-08-14
## Drug
- **FDA Application Number:** ANDA208479
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NYSTATIN AND TRIAMCINOLONE ACETONIDE
- **Generic name:** NYSTATIN, TRIAMCINOLONE ACETONIDE
- **Active ingredients:** NYSTATIN; TRIAMCINOLONE ACETONIDE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** PADAGIS ISRAEL
- **Manufacturer:** Padagis Israel Pharmaceuticals Ltd
- **First approval:** 2017-08-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208479)
---
*AI Analytics · CC0 1.0*